Neuroinflammation in schizophrenia especially focused on the role of microglia

Akira Monji, Takahiro Kato, Yoshito Mizoguchi, Hideki Horikawa, Yoshihiro Seki, Mina Kasai, Yusuke Yamauchi, Shigeto Yamada, Shigenobu Kanba

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

An accumulating body of evidence point to the significance of neuroinflammation and immunogenetics also in schizophrenia. Recent genome-wide studies in schizophrenia suggest immune involvement in schizophrenia. Microglia are the resident macrophage of the brain and major players in innate immunity in the CNS. They respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia is closely associated with microglial activation. We and other researchers have shown the inhibitory effects of some typical or atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which are not only directly toxic to neurons but also cause a decrease in neurogenesis as well as white matter abnormalities in the brains of the patients with schizophrenia. The treatment through the inhibition of microglial activation may shed new light on the therapeutic strategy of schizophrenia.

Original languageEnglish
Pages (from-to)115-121
Number of pages7
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume42
DOIs
Publication statusPublished - Apr 5 2013

Fingerprint

Microglia
Schizophrenia
Free Radicals
Brain
Cytokines
Immunogenetics
Poisons
Neurogenesis
Innate Immunity
Antipsychotic Agents
Macrophages
Research Personnel
Genome
Neurons
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Biological Psychiatry

Cite this

Neuroinflammation in schizophrenia especially focused on the role of microglia. / Monji, Akira; Kato, Takahiro; Mizoguchi, Yoshito; Horikawa, Hideki; Seki, Yoshihiro; Kasai, Mina; Yamauchi, Yusuke; Yamada, Shigeto; Kanba, Shigenobu.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 42, 05.04.2013, p. 115-121.

Research output: Contribution to journalArticle

Monji, Akira ; Kato, Takahiro ; Mizoguchi, Yoshito ; Horikawa, Hideki ; Seki, Yoshihiro ; Kasai, Mina ; Yamauchi, Yusuke ; Yamada, Shigeto ; Kanba, Shigenobu. / Neuroinflammation in schizophrenia especially focused on the role of microglia. In: Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2013 ; Vol. 42. pp. 115-121.
@article{81755a713c2d4bd88b1bb303a83bb859,
title = "Neuroinflammation in schizophrenia especially focused on the role of microglia",
abstract = "An accumulating body of evidence point to the significance of neuroinflammation and immunogenetics also in schizophrenia. Recent genome-wide studies in schizophrenia suggest immune involvement in schizophrenia. Microglia are the resident macrophage of the brain and major players in innate immunity in the CNS. They respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia is closely associated with microglial activation. We and other researchers have shown the inhibitory effects of some typical or atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which are not only directly toxic to neurons but also cause a decrease in neurogenesis as well as white matter abnormalities in the brains of the patients with schizophrenia. The treatment through the inhibition of microglial activation may shed new light on the therapeutic strategy of schizophrenia.",
author = "Akira Monji and Takahiro Kato and Yoshito Mizoguchi and Hideki Horikawa and Yoshihiro Seki and Mina Kasai and Yusuke Yamauchi and Shigeto Yamada and Shigenobu Kanba",
year = "2013",
month = "4",
day = "5",
doi = "10.1016/j.pnpbp.2011.12.002",
language = "English",
volume = "42",
pages = "115--121",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Neuroinflammation in schizophrenia especially focused on the role of microglia

AU - Monji, Akira

AU - Kato, Takahiro

AU - Mizoguchi, Yoshito

AU - Horikawa, Hideki

AU - Seki, Yoshihiro

AU - Kasai, Mina

AU - Yamauchi, Yusuke

AU - Yamada, Shigeto

AU - Kanba, Shigenobu

PY - 2013/4/5

Y1 - 2013/4/5

N2 - An accumulating body of evidence point to the significance of neuroinflammation and immunogenetics also in schizophrenia. Recent genome-wide studies in schizophrenia suggest immune involvement in schizophrenia. Microglia are the resident macrophage of the brain and major players in innate immunity in the CNS. They respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia is closely associated with microglial activation. We and other researchers have shown the inhibitory effects of some typical or atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which are not only directly toxic to neurons but also cause a decrease in neurogenesis as well as white matter abnormalities in the brains of the patients with schizophrenia. The treatment through the inhibition of microglial activation may shed new light on the therapeutic strategy of schizophrenia.

AB - An accumulating body of evidence point to the significance of neuroinflammation and immunogenetics also in schizophrenia. Recent genome-wide studies in schizophrenia suggest immune involvement in schizophrenia. Microglia are the resident macrophage of the brain and major players in innate immunity in the CNS. They respond rapidly to even minor pathological changes in the brain and may contribute directly to the neuronal degeneration by producing various pro-inflammatory cytokines and free radicals. In many aspects, the neuropathology of schizophrenia is closely associated with microglial activation. We and other researchers have shown the inhibitory effects of some typical or atypical antipsychotics on the release of inflammatory cytokines and free radicals from activated microglia, both of which are not only directly toxic to neurons but also cause a decrease in neurogenesis as well as white matter abnormalities in the brains of the patients with schizophrenia. The treatment through the inhibition of microglial activation may shed new light on the therapeutic strategy of schizophrenia.

UR - http://www.scopus.com/inward/record.url?scp=84873524397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873524397&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2011.12.002

DO - 10.1016/j.pnpbp.2011.12.002

M3 - Article

C2 - 22192886

AN - SCOPUS:84873524397

VL - 42

SP - 115

EP - 121

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

ER -